Myeloma Today: Summer 2024
The summer edition of Myeloma Today includes a report on the 2024 Summit of the IMF’s International Myeloma Working Group (IMWG), which brings together top global experts in myeloma research and clinical care who conduct collaborative basic, clinical, and translational research to improve outcomes for patients. Also in this edition is a discussion of key abstracts in myeloma presented at the annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA), as well as the unanimous vote by the FDA’s Oncologic Drugs Advisory Committee (ODAC) in favor of the use of minimal residual disease (MRD) status as an early endpoint in myeloma and MORE!